Commentary: Sglt2 Inhibitors Reduce Mortality And Heart Failure In Patients With Type 2 Diabetes Mellitus---Is Metabolic Reprogramming The Mechanism For These Favorable Outcomes?

Source: The Journal of Thoracic and Cardiovascular Surgery - Category: Cardiovascular & Thoracic Surgery Authors: Source Type: research